COMMUNIQUÉS West-GlobeNewswire

BioVie Selected for Late-Breaking Oral Presentation of Bezisterim Long COVID Data at the 4th Long COVID International Conference 2026
02/11/2026
CARSON CITY, Nev., Nov. 02, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases [...]
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Third Quarter 2026 Financial Results on November 6, 2026
02/11/2026
FREDERICK, Md., Nov. 02, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions today announced it will report results for the third [...]
LifeWorks Wellness Center Welcomes Community to New Treatment Facility
02/11/2026
CLEARWATER, Fla., Nov. 02, 2026 (GLOBE NEWSWIRE) -- LifeWorks Wellness Center marked the official opening of its new treatment facility with a ribbon-cutting ceremony on October 22. Over 100 guests gathered for the [...]
Eikon Therapeutics to Participate in Multiple Investor Conferences in November
02/11/2026
CEO Roger M. Perlmutter, M.D., Ph.D., to participate in G uggenheim 3 rd Annual Healthcare Innovation Conference Fireside Chat and JP Morgan Biotech Call series CMO Roy Baynes, M.D., Ph.D., to participate in Morgan [...]
Supernus and Indivior Complete Merger Creating a Diversified CNS Biopharmaceutical Leader
02/11/2026
Merger positions Supernus as a leading diversified central nervous system (CNS) biopharmaceutical company with a broad portfolio of marketed medicines, enhanced financial flexibility and a differentiated pipeline [...]
AnewHealth Announces Strategic Growth Investments from Linden Capital Partners and Nautic Partners
02/11/2026
Leading healthcare investors with deep pharmacy expertise partner with AnewHealth to accelerate clinical innovation and expand individualized care for people with complex medical needs. MOORESTOWN, N.J., Nov. 02, 2026 ( [...]
Family-Run Protocol Health Brings Its Physician-Led Care Nationwide Through Protocol MD, Offering GLP-1 Weight Loss, Peptide Therapy and Bloodwork Online in All 50 States
02/11/2026
Founded by cousins Dr. Richard Dentico, a board-certified physiatrist, and Joe Garvey, the Scarsdale, New York practice extends the care it built in person to patients nationwide, from the first assessment through every [...]
Pamela Anderson announced as keynote speaker for BC Women’s Health Foundation’s 2027 Illuminations Luncheon
02/11/2026
The B.C.-born actress, author, philanthropist and mother will return home for a candid conversation about transformation, reinvention, aging and women’s health this International Women’s Day VANCOUVER, British Columbia [...]
OraSure Technologies rejoint la Coalition mondiale contre la drépanocytose afin de favoriser l’accès à un diagnostic plus précoce et aux soins
02/11/2026
Cette collaboration apportera une expertise en matière de diagnostic à une initiative mondiale multipartite axée sur les politiques publiques, le plaidoyer et la mise en œuvre concrète des mesures. BETHLEHEM, [...]
OraSure Technologies Joins the World Coalition on Sickle Cell Disease to Advance Access to Earlier Diagnosis and Care
02/11/2026
Collaboration will bring diagnostics expertise to a global, multi-stakeholder effort focused on policy, advocacy, and practical implementation BETHLEHEM, Pa., Nov. 02, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc [...]
ICPO ACADEMY FOR THERANOSTICS Launches Advanced Program in Radiomolecular Precision Oncology
02/11/2026
Online curriculum expands with advanced clinical cases in prostate cancer and neuroendocrine tumors including multidisciplinary tumor board illustrations Wiesbaden, November 2, 2026 – Radiomolecular Precision Oncology, [...]
Eton Pharmaceuticals Announces Licensing and Initiation of ET-900 Program Evaluating Mecasermin/IGF-1 for Treatment of Infantile and Epileptic Spasms
02/11/2026
ET-900 targets a potential new indication for mecasermin, the active ingredient in Eton’s INCRELEX ® Eton has licensed patent rights from Baylor College of Medicine covering the use of insulin-like growth factor1 (IGF-1 [...]
Lexeo Therapeutics to Present Multiple Oral and Poster Presentations at Key Scientific Conferences in November
02/11/2026
Presentations at AHA to highlight Lexeo's cardiovascular gene therapy pipeline, including preclinical programs in desmoplakin and TNNI3 cardiomyopathies New LX2006 data to be presented at ICAR demonstrating cardiac and [...]
Tilray Brands Announces Strategy to Strengthen Canadian Cannabis Operations and Drive Profitable Growth
02/11/2026
Consolidation of Foss Cultivation and Pre-roll Production into Optimized Masson and Cayuga Facilities Expected to Generate Approximately US$10 Million in Annualized Cost Savings Higher Cultivation Yields and Expected [...]
Harrow Launches HarrowRx Platform
02/11/2026
HarrowRx to Simplify Access to Harrow Products and Integrate Into the Eyecare Practice Workflow, Providing a Single Prescribing Destination Within Existing Electronic Medical Record (EMR) Systems NASHVILLE, Tenn., Nov. [...]
Ocular Therapeutix™ to Report Third Quarter 2026 Financial Results on November 9, 2026
02/11/2026
BEDFORD, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it plans [...]
Beeline Medicines Initiates First Trial in Lupus Pivotal Development Program with Global Phase 2/3 DISCOVERY Trial of Afimetoran in Cutaneous Lupus Erythematosus (CLE)
02/11/2026
– Afimetoran, an investigational oral, once-daily, equipotent TLR7/8 inhibitor, targets a central driver of lupus biology with the potential to address both cutaneous and systemic disease – – Global, randomized, double- [...]
Can-Fite Announces Eurasian Patent Allowance Supporting Piclidenoson Development and Commercialization in Lowe Syndrome
02/11/2026
Allowed claims cover Lowe syndrome and Dent disease 2; Can-Fite holds development, commercialization, and out-licensing rights for these indications under its agreement with Fondazione Telethon Ramat Gan, Israel, Nov. [...]
Tiziana Announces Positive Topline Results from Phase 2a INFORM-MS Trial of Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis
02/11/2026
Trial met its dual primary endpoints for (1) statistically significant reduction (p=0.0168) in microglial activation as measured by TSPO PET imaging in patients treated with 50 ug nasal foralumab as compared to placebo [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum